Healthy 'N Fit Nutritionals GH Enhancers: The Growth Hormone Booster that Definitely Worth Trying

In a double-blind study, adult males participating in a 5-week progressive strength-training program who consumed 2 grams of L-arginine and 1 gram of L-ornithine experienced significantly higher total strength and lean body mass scores and excreted less urinary hydroxyproline than placebo-treated subjects.

Supplement Facts

Serving Size: 6 Caplets

Servings Per Container: 30

	Amount Per Serving	%Daily Value*
L-Arginine (HCL)	5,000 mg	*
L-Ornithine (HCL)	2,500 mg	*
Proprietary Blend - Supporting Nutrients	320 mg	*
Pituitary gland		*
Hypothalamus gland		*
Magnesium Hydroxide(specially buffered stomach acid neutralizer)		25
Calcium Ascorbate		166
Vitamin B-6 (Pyridoxine)		1,000

*Daily Value not established.

 

References

1.      Aleman A, Verhaar HJ, DeHaan EH, et al. Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab. 1999;84:471–5.[PubMed]

2.      Anawalt BD, Merriam GR. Neuroendocrine aging in men: andropause and somatopause. Endocrinology and Metabolism Clinics of North America. 2001;30:647–69.[PubMed]

3.      Arvat E, Giordano R, Broglio F, et al. GH secretagogues in aging. J Anti-Aging Medicine. 2000;3:149–58.

4.      Blackman MR, Sorkin JD, Munzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. 2002;288:2282–92.[PubMed]

5.      Bowers CY, Granda R, Mohan S, et al. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. J Clin Endocrinol Metab. 2004;89:2290–300.[PubMed]

6.      Cummings DE, Merriam GR. Growth hormone therapy in adults. Annu Rev Med. 2003;54:513.[PubMed]

7.      Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24 hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 1987;64:51–8.[PubMed]

8.      Liddle RA. Ghrelin [online] 2006. Up to Date Accessed 8 Sep 2006. URL: http://www.uptodate.com.

9.      Melmed S. Physiology of growth hormone [online] 2006. Up to Date Accessed 8 Sep 2006. URL: http://www.uptodate.com.

10.  Merriam GR, Blackman M, Hoffman A, et al. Effects of chronic treatment with an oral growth hormone (GH) secretagogue on nocturnal GH and insulin-like growth factor-I (IGF-I) in older men and women. Frontiers in Neuroendocrinology. 2006;27:36. published abstract.

11.  Merriam GR, Schwarz RS, Vitiello MV. Growth hormone-releasing hormone and growth hormone secretagogues in normal aging. Endocrine. 2003;22:1–7.[PubMed]

12.  Merriam GR, Barsness S, Buchner D, et al. Growth hormone-releasing hormone treatment in normal aging. J Anti Aging Med. 2002;4:1–13.

13.  Merriam GR, Cummings DE. Growth hormone and growth hormone secretagogues in adults. In: Meikle W, editor. Endocrine replacement therapy in clinical practice. Totowa, NJ: Humana Press; 2003. pp. 63–94.

14.  Merriam GR. Clinical Endocrinology Update. Chevy Chase, MD: The Endocrine Society; 2002. Growth hormone as anti-aging therapy, and other emerging (and submerging) indications.

15.  Merriam GR, Kletke M, Barsness S, et al. Growth hormone-releasing hormone in normal aging: An Update. Today’s Therapeutic Trends. 2000;18:335–54.

16.  Merriam GR, Buchner DM, Prinz PN, et al. Potential applications of GH secretagogs in the evaluation and treatment of the age-related decline in growth hormone secretion. Endocrine. 1997;7:1–3.[PubMed]

17.  Merriam GR, Wyatt FG. Diagnosis and treatment of growth hormone deficiency in adults: current perspectives. Current Opinion in Endocrinology and Diabetes. 2006;13:362–8.

18.  Molitch M, Clemmons D, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2006;91:1621–34.[PubMed]

19.  Papadakis MA, Grady D, Black D, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med. 1996;124:708–16.[PubMed]

20.  Pavlov EP, Harman SM, Merriam GR, et al. Responses of growth hormone and somatomedin-C to growth hormone-releasing hormone in healthy aging men. J Clin Endocrinol Metab. 1986;62:595–600.[PubMed]

21.  Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. NEJM. 1990;323:1–6.[PubMed]

22.  Thorner MO, Nass R, Pezzoli SS, et al. Orally active ghrelin mimetic (MK-677) prevents and partially reverses sarcopenia in healthy older men and women: a double-blind, placebo controlled, crossover study. Endocrine Society Annual Meeting; 24 June 2006; Boston. 2006. abstract OR5–5.

23.  Veldhuis JD, Patri JM, Frick K, et al. Administration of recombinant human GHRH-1,44-amide for 3 months reduces abdominal visceral fat mass and increases physical performance measures in postmenopausal women. Eur J Endocrinol. 2005;153:669–77.[PubMed]

24.  Vitiello MV, Moe KE, Merriam GR, et al. Chronic growth hormone releasing hormone treatment improves cognition of healthy older adults. Neurobiology of Aging. 2006;27:318–23.[PubMed]

25.  Vitiello MV, Schwartz RS, Buchner KE, et al. Treating age-related changes in somatotrophic hormones, sleep, and cognition. Dialogs in Clinical Neuroscience. 2001;3:229–36.

26.  Vitiello MV, Wilkinson CW, Merriam GR, et al. Successful six-month endurance training does not alter insulin-like growth factor-I in healthy older men and women. J Gerontol Med Sci. 1997;52A:149–54.